VIPR2 antibody (N-Term) (HRP)
Quick Overview for VIPR2 antibody (N-Term) (HRP) (ABIN8053528)
Target
See all VIPR2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purpose
- Anti-VPAC2/VIPR2 Antibody HRP Conjugated
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the N-terminus of human VPAC2/VIPR2, which shares 94.4% and 85% amino acid (aa) sequence identity with mouse and rat VIPR2, respectively.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing.
-
Expiry Date
- 12 months
-
-
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
-
Alternative Name
- VIPR2
-
Background
-
Background: Vasoactive intestinal peptide receptor 2 also known as VPAC2, is a G-protein coupled receptor that in humans is encoded by the VIPR2 gene. This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase.
Gene Full Name: vasoactive intestinal peptide receptor 2
-
Gene ID
- 7434
-
UniProt
- P41587
-
Pathways
- cAMP Metabolic Process
Target
-